NICE backs Novartis asthma drug in fresh U-turn

[riky]

NICE backs Novartis asthma drug in fresh U-turn

<p><a href="http://news.yahoo.com/nice-backs-novartis-asthma-drug-fresh-u-turn-000745001--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/mn3S5_xLxXLLwDJmzP9XJA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-07T000745Z_1_CBRE92600CZ00_RTROPTP_2_NOVARTIS.JPG" width="130" height="86" alt="A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln" align="left" title="A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln" border="0" /></a>LONDON (Reuters) - Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health Service (NHS). The National Institute for Health and Clinical Excellence (NICE) said on Thursday it had reversed a November decision in the light of extra analyses and a move by Novartis to offer a so-called patient access scheme to discount Xolair's list price. Xolair works by blocking immunoglobulin E (IgE) antibodies from attaching to ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login